Eutropics Pharmaceuticals, Inc. — Form D
Eutropics Pharmaceuticals, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-01-11. The offering totals $350K. Industry: Pharmaceuticals.
Offering
- Filed: 2024-01-11
- Form: D
- Accession: 0001892756-24-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $350K
- Remaining: $350K
- Revenue range: Decline to Disclose
- SEC file number: 021-502177
Issuer
- Name: Eutropics Pharmaceuticals, Inc.
- CIK: 0001892756
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 767 CONCORD AVENUE, CAMBRIDGE, MA, 02138
- Phone: 617-714-4405
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Michael Cardone | Director | Cambridge, MA |
| Michael Cardone | Executive Officer | Cambridge, MA |
Other filings by this issuer (1)
More